Stockscreener 앱 받기
9.20
2.34%
0.21
시장 영업 전:
9.30
0.10
+1.09%
Exagen Inc 주식(XGN)의 최신 뉴스
Comparing Exagen Inc. in custom built stock radarsCapital Growth Summary Over Five Years - Newser
Exagen Inc. Recovery Gathers Momentum on Chart SignalsAI Based High Gain Watchlist Scanner Shared - beatles.ru
Is Exagen Inc. reversing from oversold territorySafe Entry Zone Based on Chart Analysis - Newser
What makes Exagen Inc. stock price move sharplyBreakout Screener With Alert Based Timing - Newser
What’s next for Exagen Inc. stock priceReversal Signal Prediction Based on Volume - Newser
Building trade automation scripts for Exagen Inc.Free ROI Boosting Trade Opportunity Calendar - Newser
Applying big data sentiment scoring on Exagen Inc.Weekly Entry Signal Based Forecast Tool - Newser
Exagen Inc. to Participate in Third Quarter Investor Conferences - The Manila Times
Exagen Doubles Down on Investor Outreach: Set for Major Healthcare Conference Circuit - Stock Titan
Exagen Inc.'s (NASDAQ:XGN) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - simplywall.st
What drives Exagen Inc. stock priceFree Stock Market Beginners Guide - Jammu Links News
What are the latest earnings results for Exagen Inc.Discover breakthrough trading strategies - Jammu Links News
Is Exagen Inc. a good long term investmentMaximize your gains with expert trading tips - Jammu Links News
What are Exagen Inc. company’s key revenue driversBreakthrough financial growth - Jammu Links News
What are analysts’ price targets for Exagen Inc. in the next 12 monthsSuperior returns - Jammu Links News
What is the risk reward ratio of investing in Exagen Inc. stockBreakthrough profit margins - Jammu Links News
What catalysts could drive Exagen Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
Is Exagen Inc. a growth stock or a value stockInvest smarter with advanced market data - Jammu Links News
Is Exagen Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
Is it the right time to buy Exagen Inc. stockRemarkably fast returns - Jammu Links News
What is the dividend policy of Exagen Inc. stockUnmatched profit potential - Jammu Links News
Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline - MSN
Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Exagen Inc. stock outlook for YEARStock Performance Summary Over One Year - Newser
Exagen Inc. Reports Record Revenue Amidst Growth Challenges - The Globe and Mail
What markets is Exagen Inc. expanding into Is LILA stock a good long term investment optionExpert Picks Data Feed For Consistent Profits - Jammu Links News
Personalized Medicine Market Future Business Opportunities - openPR.com
What risks could impact Exagen Inc. stock performanceDaily Upside Movement Prediction With Data - Newser
Exagen Analyst Ratings: Bullish Sentiment Dominates - AInvest
Exagen's Q2 Growth Validates Buy Rating, Analyst Says - AInvest
Exagen price target raised to $11 from $8 at Canaccord - TipRanks
Exagen price target raised to $10 from $7 at Cantor Fitzgerald - TipRanks
Canaccord Genuity Sticks to Its Buy Rating for Exagen (XGN) - The Globe and Mail
Exagen stock price target raised to $10 from $7 at Cantor Fitzgerald - Investing.com Nigeria
Exagen stock price target raised to $10 from $7 at Cantor Fitzgerald By Investing.com - Investing.com South Africa
KeyBanc upgrades Exagen on improved revenue visibility - TipRanks
Visual analytics tools that track Exagen Inc. performanceLow Risk Stock Selection Strategy Guide - Newser
KeyBanc upgrades Exagen stock to Overweight on improved pricing and growth - Investing.com Nigeria
Chart based analysis of Exagen Inc. trendsTop Stock Picks with Forecast Accuracy - Newser
Key metrics from Exagen Inc.’s quarterly dataHigh Probability Trade Outcome Prediction - Newser
Why Exagen Inc. stock attracts strong analyst attentionLow Risk Stock Selection Strategy Guide - Newser
Exagen Reports Record Q2 2025 Revenue of $17.2M, Announces Strategic Updates - AInvest
Exagen Inc. Reports Record Q2 2025 Revenue - TipRanks
Exagen 2025 Q2 Earnings Misses Targets as Net Loss Widens 49.7% - AInvest
Exagen Q2 Revenue Jumps 14 Percent - AOL.com
1.15%
자본화:
|
볼륨(24시간):